Active Substance: PNC-27 Anti-Cancer Peptide
Concentration: 5 mg
Pack Size: vial
Manufacturer: Deus Medical
Brand Name: PNC-27
SKU: P374
Shipping From
PNC-27 is a novel anti-cancer peptide designed for targeted therapy against cancer cells. It has garnered attention for its potential to selectively induce apoptosis (programmed cell death) in cancerous cells while sparing normal tissues, making it a promising candidate in cancer treatment.
Product Overview
PNC-27 is a peptide that binds to specific receptors on cancer cells, triggering a cascade of events that lead to cell death. This mechanism allows for effective targeting of tumors while minimizing side effects associated with conventional therapies. PNC-27 is under investigation for its efficacy in various types of cancer.
Usage and Dosage
The dosage and administration of PNC-27 are currently being evaluated in clinical trials. Users should consult a healthcare provider or oncologist for tailored dosing recommendations based on individual conditions and ongoing research findings.
Side Effects & Management
As PNC-27 is still undergoing research, the safety profile is not fully established. Potential side effects may include localized reactions at the injection site, fatigue, and gastrointestinal disturbances. Continuous monitoring and consulting with a healthcare provider are essential for managing any adverse effects effectively.
Patient Safety Information
This product is intended for patients under medical supervision, particularly those diagnosed with cancer. It should be used as part of a comprehensive treatment plan overseen by a qualified healthcare professional.
FAQs
What benefits can I expect from using PNC-27?
PNC-27 may offer targeted anti-cancer effects with potentially fewer side effects compared to traditional therapies.
How is PNC-27 administered?
It is typically administered via injection, but specific protocols will depend on ongoing clinical research and healthcare provider recommendations.
Is PNC-27 safe for long-term use?
Long-term safety has not been fully evaluated; therefore, it is crucial to use PNC-27 under the guidance of a healthcare provider.